Drug application
AMBENYL (BROMODIPHENHYDRAMINE HYDROCHLORIDE, CODEINE PHOSPHATE)
Drugs@FDA NDA 009319 · FOREST LABS
Key facts
| Drug name | AMBENYL |
|---|---|
| Active ingredients | BROMODIPHENHYDRAMINE HYDROCHLORIDE, CODEINE PHOSPHATE |
| Application type | NDA |
| Application number | 009319 |
| Company | FOREST LABS |
| Dosage forms | SYRUP, ORAL |
| Strength | 12.5MG/5ML;10MG/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Apr 28, 1954 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.